One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist

被引:53
作者
Johnson, K
Farley, D
Hu, SL
Terkeltaub, R
机构
[1] Dept Vet Adm Med Ctr, La Jolla, CA 92161 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Novartis Pharmaceut, Summit, NJ USA
来源
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 05期
关键词
D O I
10.1002/art.10927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Aging and osteoarthritic (OA) cartilage commonly demonstrate enhanced expression of the large, transforming growth factor beta (TGFbeta)-inducible glycoprotein cartilage intermediate-layer protein (CILP) as well as enhanced extracellular inorganic pyrophosphate (PPi) that promotes the deposition of calcium pyrophosphate dihydrate crystals. In normal chondrocytes, TGFbeta induces elevated chondrocyte extracellular PPi. Insulin-like growth factor 1 (IGF-1) normally blocks this response and reduces extracellular PPi. However, chondrocyte resistance to IGF-1 is observed in OA and aging. Because CILP was reported to chromatographically fractionate with PPi-generating nucleotide pyrophosphatase phosphodiesterase (NPP). activity, it has been broadly assumed that CILP itself has NPP activity. Our objective was to directly define CILP functions and their relationship to IGF-1 in chondrocytes. Methods. Using primary cultures of articular chondrocytes from the knee, we defined the function of the previously described CILP (CILP-1) and of a recently described 50.6% identical protein that we designated the CILP-2 isoform. Results. Both CILP isoforms were constitutively expressed by primary cultured articular chondrocytes, but only CILP-I expression was detectable in cultured knee meniscal cartilage cells. Neither CILP isoform had intrinsic NPP activity. But CILP-1 blocked the ability of IGF-1 to decrease extracellular PPi, an activity specific for the CILP-1 N-terminal domain. The CILP-1 N-terminal domain also suppressed IGF-1-induced (but not TGFbeta-induced) proliferation and sulfated proteoglycan, synthesis, and it inhibited ligand-induced IGF-1 receptor autophosphorylation. Conclusion. Two CILP isoforms are differentially expressed by chondrocytes. Neither CILP isoform exhibits PPi-generating NPP activity. But, increased expression of CILP-1, via N-terminal domain-mediated inhibitory effects of CILP-1 on chondrocyte IGF-1 responsiveness, could impair chondrocyte growth and matrix repair and indirectly promote PPi supersaturation in aging and OA cartilage.
引用
收藏
页码:1302 / 1314
页数:13
相关论文
共 60 条
  • [21] Johnson K, 2001, ARTHRITIS RHEUM, V44, P1071, DOI 10.1002/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO
  • [22] 2-3
  • [23] JOHNSON K, 2000, AM J PHYSIOL-CELL PH, V269, pR1365
  • [24] Loeser RF, 2000, ARTHRITIS RHEUM, V43, P2110, DOI 10.1002/1529-0131(200009)43:9<2110::AID-ANR23>3.0.CO
  • [25] 2-U
  • [26] Loeser RF, 2000, ARTHRITIS RHEUM-US, V43, P1552, DOI 10.1002/1529-0131(200007)43:7<1552::AID-ANR20>3.3.CO
  • [27] 2-N
  • [28] A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age
    Lorenzo, P
    Bayliss, MT
    Heinegård, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) : 23463 - 23468
  • [29] The human CILP gene:: exon/intron organization and chromosomal mapping
    Lorenzo, P
    Åman, P
    Sommarin, Y
    Heinegård, D
    [J]. MATRIX BIOLOGY, 1999, 18 (05) : 445 - 454
  • [30] Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a preform including a nucleotide pyrophosphohydrolase
    Lorenzo, P
    Neame, P
    Sommarin, Y
    Heinegård, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) : 23469 - 23475